Tanzanians vie for grant
DAR ES SALAAM, TANZANIA--TANZANIAN scientists are among researchers across Sub-sahara Africa, who stand to win £100,000 (some $168,000) from a science-led global healthcare company engaged in research and development of Pharmaceuticals, Vaccines and Consumer Healthcare in GSK’S Africa Non-communicable Disease (NCD) Open Lab research funding writes TIMOTHY KITUNDU
Launched in 2014, The Africa NCD Open Lab is part of a series of investments GSK is making across sub-saharan Africa. Through the program, GSK aims to work in partnership with African researchers and academic groups to conduct research into NCDS such as cancer, diabetes, cardiovascular disease and chronic respiratory diseases.
According to a statement from GSK to media houses last week, the third call for research proposal to address these growing challenges is open from November 7th, 2016 until January 12th 2017 and successful applicants will be awarded £100,000 for up to two years, along with scientific support from GSK.
It is hoped that the vital research will improve the understanding of NCDS, and inform best practice, prevention and treatment strategies.
“I encourage scientists who are interested to visit our website, http://www.gsk. com/en-gb/research/open-innovation/ africa-ncd-open-lab where information on submitting the proposal can be found,” Beno Mbeya, the GSK Medical Advisor in Tanzania said last week.
Statistics indicate that by 2014, NCDS accounted for nearly a third or 32% of total deaths in Tanzania, while across the country, the probability of dying at the ages of between 30 and 70 years from an NCD is 16%.
Mbeya said whilst huge progress has been made in recent years to understand and combat infectious diseases, more work needs to be done to tackle the growing health concern presented by NCDS in Tanzania and across Sub-saharan Africa and that when an issue is better understood it can be more effectively tackled.
Mbeya said by collaborating with GSK’S research network across Africa through the Open Lab program, Tanzanian scientists can work to vastly improve the understanding of NCDS in Tanzania and beyond.